SE7503542L - - Google Patents

Info

Publication number
SE7503542L
SE7503542L SE7503542A SE7503542A SE7503542L SE 7503542 L SE7503542 L SE 7503542L SE 7503542 A SE7503542 A SE 7503542A SE 7503542 A SE7503542 A SE 7503542A SE 7503542 L SE7503542 L SE 7503542L
Authority
SE
Sweden
Prior art keywords
compound
parenteral administration
diisopropylphenol
warm
pharmaceutical compositions
Prior art date
Application number
SE7503542A
Other languages
Unknown language ( )
English (en)
Inventor
John B Glen
Roger James
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of SE7503542L publication Critical patent/SE7503542L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7503542A 1974-03-28 1975-03-26 SE7503542L (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1373974A GB1472793A (en) 1974-03-28 1974-03-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE7503542L true SE7503542L (OSRAM) 1975-09-29

Family

ID=10028495

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7503542A SE7503542L (OSRAM) 1974-03-28 1975-03-26

Country Status (22)

Country Link
US (2) US4056635A (OSRAM)
JP (1) JPS50154410A (OSRAM)
AU (1) AU502164B2 (OSRAM)
BE (1) BE827290A (OSRAM)
CA (1) CA1038764A (OSRAM)
DE (1) DE2513797C2 (OSRAM)
DK (1) DK128675A (OSRAM)
DO (1) DOP1980002892A (OSRAM)
FI (1) FI750941A7 (OSRAM)
FR (1) FR2265357B1 (OSRAM)
GB (1) GB1472793A (OSRAM)
HK (1) HK34380A (OSRAM)
IE (1) IE40839B1 (OSRAM)
IL (1) IL46899A (OSRAM)
KE (1) KE3052A (OSRAM)
MY (1) MY8100111A (OSRAM)
NL (2) NL183079C (OSRAM)
NO (1) NO751076L (OSRAM)
NZ (1) NZ177023A (OSRAM)
PH (1) PH13553A (OSRAM)
SE (1) SE7503542L (OSRAM)
ZA (1) ZA751806B (OSRAM)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
MY113046A (en) * 1994-03-22 2001-11-30 Astrazeneca Uk Ltd Pharmaceutical compositions
IT1269977B (it) 1994-07-01 1997-04-16 Archimica Spa Purificazione del propofol
IT1270093B (it) 1994-09-28 1997-04-28 Zambon Spa Processo per la purificazione di 2,6-diisopropilfenolo
CN1106192C (zh) * 1995-03-17 2003-04-23 曾尼卡有限公司 含2,6－二异丙基苯酚和乙二胺四乙酸盐的水包油型乳液
CN100457086C (zh) * 1995-03-17 2009-02-04 曾尼卡有限公司 无菌医药组合物
WO1997010814A1 (en) * 1995-09-18 1997-03-27 Vesifact Ag Propofol nanodispersions
WO1997014407A1 (en) * 1995-10-17 1997-04-24 Research Triangle Pharmaceuticals Insoluble drug delivery
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
CH692322A5 (it) * 1997-05-26 2002-05-15 Westy Ag Formulazione iniettabile limpida di Propofol.
US8853260B2 (en) * 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
DE19757224A1 (de) 1997-12-22 1999-07-01 Bayer Ag Verfahren und Vorrichtung zur in-situ-Formulierung einer Arzneistofflösung zur parenteralen Applikation
US6147122A (en) * 1998-02-10 2000-11-14 Gensia Sincor Inc. Propofol composition containing sulfite
AU762246B2 (en) * 1998-02-11 2003-06-19 Rtp Pharma Corporation Method and composition for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
KR100635456B1 (ko) 1998-05-29 2006-10-18 스키에파마 캐나다 인코포레이티드 열보호화 마이크로입자 조성물 및 그의 말단의 스팀멸균방법
ATE252889T1 (de) 1998-08-19 2003-11-15 Skyepharma Canada Inc Injizierbare wässerige propofoldispersionen
US6150423A (en) * 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6028108A (en) * 1998-10-22 2000-02-22 America Home Products Corporation Propofol composition comprising pentetate
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
HK1042856B (zh) 1998-11-20 2007-07-27 Skyepharma Canada Inc. 可分散的磷脂稳定的微粒
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6100302A (en) * 1999-04-05 2000-08-08 Baxter International Inc. Propofol formulation with enhanced microbial characteristics
US6743436B1 (en) * 1999-06-21 2004-06-01 Kuhnil Pharm. Co., Ltd. Anesthetic composition for intravenous injection comprising propofol
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
KR100386397B1 (ko) * 2000-04-19 2003-06-02 센츄론(주) 투명한 프로포폴 주사제
AU5711501A (en) 2000-04-20 2001-11-07 Rtp Pharma Inc Improved water-insoluble drug particle process
EP1292282A2 (en) 2000-06-16 2003-03-19 RTP Pharma Inc. Improved injectable dispersions of propofol
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
WO2002017883A2 (en) 2000-08-31 2002-03-07 Rtp Pharma Inc. Milled particles
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US20030096013A1 (en) * 2000-12-22 2003-05-22 Jane Werling Preparation of submicron sized particles with polymorph control
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6951656B2 (en) * 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US8067032B2 (en) * 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6607784B2 (en) * 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
PL202778B1 (pl) * 2001-02-22 2009-07-31 Skyepharma Canada Inc Postać dawkowana kombinacji statyny i fenofibratu, sposób jej wytwarzania i zastosowanie
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
JP4127757B2 (ja) * 2001-08-21 2008-07-30 株式会社エヌ・ティ・ティ・ドコモ 無線通信システム、通信端末装置、及びバースト信号送信方法
GB0120702D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Anaesthetic formulations
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
WO2003026632A2 (en) 2001-09-26 2003-04-03 Theravance, Inc. Substituted phenol compounds useful for anesthesia and sedation
CN1558755A (zh) 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
GB0124071D0 (en) * 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
CA2470500C (en) * 2001-12-28 2012-05-15 Guilford Pharmaceuticals, Inc. Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
JP3931680B2 (ja) * 2002-02-18 2007-06-20 株式会社日本自動車部品総合研究所 車両の直進判別装置
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
BR0313060A (pt) * 2002-07-29 2005-06-28 Transform Pharmaceuticals Inc Composições farmacêuticas aquosas de 2,6-diisopropilfenol
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US20040171691A1 (en) * 2002-10-29 2004-09-02 Transform Pharmaceuticals, Inc. Propofol with cysteine
EP1556022A4 (en) * 2002-10-29 2010-03-10 Transform Pharmaceuticals Inc Aqueous 2,6-diisopropylprophenol-containing pharmaceutical compositions
AU2003284669B2 (en) * 2002-11-26 2009-11-12 Maruishi Pharmaceutical Co., Ltd. Isoindoline derivative
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
ES2348303T3 (es) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Composiciones farmacauticas y procedimientos de tratamiento con insulina.
JP2007520555A (ja) * 2004-02-05 2007-07-26 バクスター・インターナショナル・インコーポレイテッド 自己安定化剤の使用により調製された分散剤
BRPI0612071A2 (pt) * 2005-06-14 2010-10-19 Baxter Int formulações farmacêuticas para minimizar interações entre fármacos
US20060280787A1 (en) * 2005-06-14 2006-12-14 Baxter International Inc. Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
US20100048732A1 (en) * 2006-05-30 2010-02-25 Emala Sr Charles W Method of mediating Airway Smooth Muscle Construction Due to Airway Irritation
US7705191B2 (en) * 2006-07-13 2010-04-27 University Of Iowa Research Foundation Hydrofluoroalkyl phenols having anesthetic properties
WO2008080047A2 (en) * 2006-12-23 2008-07-03 Baxter International Inc. Magnetic separation of fine particles from compositions
ES2501592T3 (es) 2007-05-09 2014-10-02 Sowood Healthcare Llc Estereoisómero (-) de 2,6-di-sec-butilfenol y análogos del mismo para fomentar el efecto antiemético, tratamiento de náuseas y vómitos y tratamiento de migraña
EP2152651B1 (en) 2007-05-09 2012-01-04 Pharmacofore, Inc. Therapeutic compounds
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US20090198145A1 (en) * 2008-02-06 2009-08-06 Chow Harrison Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
US20180022698A1 (en) 2014-10-16 2018-01-25 The Board Of Trustees Of The Leland Stanford Junior University Novel methods, compounds, and compositions for anesthesia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2104412A (en) * 1931-12-29 1938-01-04 Standard Oil Dev Co Alkyl phenols
GB831071A (en) 1956-04-26 1960-03-23 British Schering Ltd Analgesic compounds
GB803080A (en) 1956-07-06 1958-10-15 Scient Oil Compounding Co Inc Bacteriostatic compositions
US2966442A (en) * 1956-09-20 1960-12-27 American Home Prod Antibiotic compositions
US3476838A (en) * 1958-12-04 1969-11-04 Ethyl Corp Di(2,6-diisopropylphenyl) mono halo phosphite or (thio) phosphate
US3067106A (en) * 1959-04-07 1962-12-04 Foundation For Prosthetic Res Skin treating method and composition

Also Published As

Publication number Publication date
GB1472793A (en) 1977-05-04
NL930084I1 (nl) 1993-09-16
NZ177023A (en) 1984-09-28
FR2265357B1 (fr) 1978-08-04
HK34380A (en) 1980-07-01
IE40839B1 (en) 1979-08-29
NL930084I2 (nl) 1994-10-17
US4452817A (en) 1984-06-05
AU7953675A (en) 1976-09-30
FI750941A7 (OSRAM) 1975-09-29
IL46899A0 (en) 1975-06-25
DE2513797A1 (de) 1975-10-09
NL183079C (nl) 1988-07-18
PH13553A (en) 1980-06-26
BE827290A (fr) 1975-09-29
DE2513797C2 (de) 1987-07-30
NO751076L (OSRAM) 1975-09-30
JPS50154410A (OSRAM) 1975-12-12
AU502164B2 (en) 1979-07-12
IE40839L (en) 1975-09-28
ZA751806B (en) 1976-02-25
IL46899A (en) 1978-03-10
FR2265357A1 (fr) 1975-10-24
KE3052A (en) 1980-06-27
CA1038764A (en) 1978-09-19
DK128675A (de) 1975-09-29
NL7503696A (nl) 1975-09-30
US4056635A (en) 1977-11-01
DOP1980002892A (es) 1989-10-04
MY8100111A (OSRAM) 1981-12-31

Similar Documents

Publication Publication Date Title
SE7503542L (OSRAM)
SE7613959L (sv) Antibiotisk komposition och forfarande for framstellning derav
HUT44441A (en) Process for preparing antineoplastic pharmaceutical composition
EP0014958B1 (en) Process for the preparation of 4,5-perfluoro-1,3-dioxolanes
JPS51139617A (en) A process for preparing a remedy for intestinal infectious diseases
DE2966179D1 (en) Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same
ES458967A1 (es) Un procedimiento para la preparacion de una composicion de prostaglandina estabilizada.
ES449093A1 (es) Procedimiento para la preparacion de 1,2,2,2-tetrafluoroe- til-eteres.
PH24207A (en) 2-acylamino-6-amino-4,5,6,7-tetrahydrobenzothiazoles
JPS57209268A (en) Medicinal use of 16-methyl-1,11 alpha,16rs- trihydroxyprost-13e-en-9-one
SE8305386D0 (sv) 15-cycloaliphatic derivatives of 13,14-didehydro-carboprostacyclins and process for their preparation
SE7507667L (sv) Sett att framstella 2-substituerade 5-oxo-5h-dibenso (a,d)-cukloheptener och anvendning derav som lekemedel
DE3476398D1 (en) An anthracycline compound, a process for the production thereof, a pharmaceutical composition containing the same and its use as a medicament
IE42100L (en) Process for the preparation of 2, 2, 2-trichloroethyl¹chloroformate
SE7509607L (sv) Forfarnde for framstellning av 9,11,15-trihydroxi-13,14-dehydroprostaglandiner och prost-5-en-13-ynsyraderivat
AU490537B2 (en) A process for preparing 1, 3 thiazane and 1, 3 thiazine derivatives, andthe compounds so produced
SE7502232L (sv) Sett att framstella 3-oxo-17beta-n-amyloxi-estra-4,9,11-trien
CA953741A (en) Process for producing bicyclo-(3,3,0)-octene-(2)
IL36584A0 (en) Bis(4-substituted-3,5-dinitrophenyl)disulfide compounds and process for preparing same
BE830576A (fr) Derives actifs d'acetoxime, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
CS184786B2 (en) Method for producing novel 3beta-/4'-oxo-alfa-l-rhamnosyl/-14beta-hydroxy-bufa-4,20,22-trienolide
CA866777A (en) Procede de preparation de derive steroides insatures substitues par un atome d'oxygene endocyclique
AU485558B2 (en) N, n'disubstituted naphthaleneacetamidines
GB1475651A (en) Pharmaceutical composition for the treatment of cancer
JPS5241242A (en) Method of killing tape worm imagoes